Related Experiment Video
Updated: Apr 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma
Irena Misiewicz-Krzeminska1, María E Sarasquete2, Carolina Vicente-Dueñas3
1Centro de Investigacion del Cancer-IBMCC (USAL-CSIC), Salamanca, Spain. Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. National Medicines Institute, Warsaw, Poland.
Purpose:
Dysregulation of one of the three D-cyclin genes has been observed in virtually all multiple myeloma tumors. The mechanisms by which CCND2 is upregulated in a set of multiple myeloma are not completely deciphered. We investigated the role of post-transcriptional regulation through the interaction between miRNAs and their binding sites at 3'UTR in CCND2 overexpression in multiple myeloma.
Experimental Design:
Eleven myeloma cell lines and 45 primary myeloma samples were included in the study. Interactions between miRNAs deregulated in multiple myeloma and mRNA targets were analyzed by 3'UTR-luciferase plasmid assay. The presence of CCND2 mRNA isoforms different in length was explored using qRT-PCR, Northern blot, mRNA FISH, and 3' rapid amplification of cDNA ends (RACE)-PCR.
Results:
We detected the presence of short CCND2 mRNA, both in the multiple myeloma cell lines and primary cells. The results obtained by 3'RACE experiments revealed that changes in CCND2 3'UTR length are explained by alternative polyadenylation. The luciferase assays using plasmids harboring the truncated CCND2 mRNA strongly confirmed the loss of miRNA sites in the shorter CCND2 mRNA isoform. Those multiple myelomas with greater abundance of the shorter 3'UTR isoform were associated with significant higher level of total CCND2 mRNA expression. Furthermore, functional analysis showed significant CCND2 mRNA shortening after CCND1 silencing and an increased relative expression of longer isoform after CCND1 and CCND3 overexpression, suggesting that cyclin D1 and D3 could regulate CCND2 levels through modifications in polyadenylation-cleavage reaction.
Conclusions:
Overall, these results highlight the impact of CCND2 3'UTR shortening on miRNA-dependent regulation of CCND2 in multiple myeloma.
Insights
Shortened CCND2 mRNA 3'UTRs in multiple myeloma lead to altered miRNA regulation and increased gene expression. This occurs via alternative polyadenylation, impacting cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Dysregulation of D-cyclin genes is common in multiple myeloma.
- Mechanisms of CCND2 (Cyclin D2) upregulation in multiple myeloma are not fully understood.
- Post-transcriptional regulation via microRNAs (miRNAs) is a potential factor.
Purpose of the Study:
- To investigate the role of miRNA interactions with CCND2 3 e202UTR binding sites in CCND2 overexpression.
- To explore the impact of 3 e202UTR length variations on CCND2 regulation in multiple myeloma.
- To elucidate the mechanisms behind CCND2 upregulation in multiple myeloma.
Main Methods:
- Analysis of miRNA-mRNA interactions using 3 e202UTR-luciferase plasmid assays.
- Detection and characterization of CCND2 mRNA isoforms using qRT-PCR, Northern blot, mRNA FISH, and 3 e202RACE-PCR.
- Study included 11 myeloma cell lines and 45 primary myeloma samples.
Main Results:
- Short CCND2 mRNA isoforms with truncated 3 e202UTRs were detected in multiple myeloma cells.
- Alternative polyadenylation was identified as the cause of CCND2 3 e202UTR length variations.
- Shorter CCND2 mRNA isoforms correlated with higher CCND2 expression and reduced miRNA binding sites.
- Cyclin D1 and D3 overexpression influenced CCND2 polyadenylation, suggesting a regulatory role.
Conclusions:
- CCND2 3 e202UTR shortening significantly impacts miRNA-dependent regulation of CCND2 in multiple myeloma.
- Alternative polyadenylation of CCND2 contributes to its overexpression in multiple myeloma.
- Findings highlight a novel mechanism of gene regulation in multiple myeloma progression.
More Related Videos
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

